Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMATINIB vs IMIPRAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMATINIB vs IMIPRAMINE: Safety Overview

Metric IMATINIB IMIPRAMINE
Total FAERS Reports 43,161 1,077
Deaths Reported 13,761 242
Death Rate 31.9% 22.5%
Hospitalizations 7,264 338
Average Patient Age 55.7 yrs 50.3 yrs
% Female Patients 47.2% 59.4%
FDA Approval Date Apr 14, 2025 Approved Prior to Jan 1, 1982
Manufacturer Dr.Reddy's Laboratories Inc Advanced Rx Pharmacy of Tennessee, LLC
Route ORAL ORAL
Marketing Status Discontinued Discontinued